factors, which included the severity of COVID-19, acute coronary syndrome,
multiple organ failure
Rafikova, G.,
Piatnitskaia, S.,
Shapovalova, E.,
Chugunov, S.,
Kireev, V.,
Ialiukhova, D.,
Bilyalov, A.,
Pavlov, V.,
Kzhyshkowska, J. (2023) modification and pointed out the need for data integration using mathematic
modelling of the
multiple ceramic
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Holz, Frank G.,
Panda-Jonas, Songhomitra,
Gilemzianova, Leisan I.,
Khakimov, Dinar A.,
Jonas, Jost B. (2023) with pathological myopia. Methods: The clinical, monocentre, open-label,
multiple-dose, phase-1 study included
Kazantseva, A.V.,
Davydova, Yu. D.,
Enikeeva, R.F.,
Yakovleva, D.V.,
Mustafin, R.N.,
Lobaskova, M.M.,
Malykh, S.B.,
Khusnutdinova, E.K. (2023) -measured aggression in young adults from the Volga-Ural region (VUR) of Russia. Initially, a series of
multiple linear
Shnayder, N.A.,
Grechkina, V.V.,
Khasanova, A.K.,
Bochanova, E.N.,
Dontceva, E.A.,
Petrova, M.M.,
Asadullin, A.R.,
Shipulin, G.A.,
Altynbekov, K.S.,
Al-Zamil, M.,
Nasyrova, R.F. (2023) -modifying therapy for
multiple tumors, neurodegenerative diseases (Huntington’s disease, Parkinson’s disease
Kazantseva, A.,
Enikeeva, R.,
Takhirova, Z.,
Davydova, Y.,
Mustafin, R.,
Malykh, S.,
Karunas, A.,
Kanapin, A.,
Khusnutdinova, E. (2023) To date,
multiple efforts have been made to use genome-wide association studies (GWAS) to untangle